Suppr超能文献

相似文献

1
What should we recommend to our patients with NAFLD regarding alcohol use?
Am J Gastroenterol. 2012 Jul;107(7):976-8. doi: 10.1038/ajg.2012.20.
2
Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Scand J Gastroenterol. 2009;44(3):366-74. doi: 10.1080/00365520802555991.
3
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
Hepatology. 2017 Jun;65(6):2090-2099. doi: 10.1002/hep.29055. Epub 2017 Apr 28.
6
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2020 Oct;26(4):662-669. doi: 10.3350/cmh.2020.0163. Epub 2020 Sep 25.
7
Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.
Liver Int. 2014 Jan;34(1):129-35. doi: 10.1111/liv.12230. Epub 2013 Jun 28.
8
Effect of alcohol consumption on nonalcoholic fatty liver disease.
Transl Gastroenterol Hepatol. 2019 Sep 17;4:70. doi: 10.21037/tgh.2019.09.02. eCollection 2019.
9
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.
Semin Liver Dis. 2020 May;40(2):154-162. doi: 10.1055/s-0040-1701443. Epub 2020 Feb 18.
10
Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1831-1841.e5. doi: 10.1016/j.cgh.2019.11.022. Epub 2019 Nov 14.

引用本文的文献

3
Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis.
Transl Gastroenterol Hepatol. 2021 Oct 25;6:60. doi: 10.21037/tgh-20-247. eCollection 2021.
6
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Nutrients. 2019 Dec 13;11(12):3048. doi: 10.3390/nu11123048.
8
Liver Cholestasis Secondary to Syphilis in an Immunocompetent Patient.
Case Reports Hepatol. 2018 Oct 22;2018:8645068. doi: 10.1155/2018/8645068. eCollection 2018.
9
Alcoholic liver disease.
Nat Rev Dis Primers. 2018 Aug 16;4(1):16. doi: 10.1038/s41572-018-0014-7.
10
A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.
Liver Int. 2018 Aug;38(8):1495-1503. doi: 10.1111/liv.13709. Epub 2018 Mar 12.

本文引用的文献

2
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk.
JAMA. 2011 Nov 2;306(17):1884-90. doi: 10.1001/jama.2011.1590.
3
Alcohol consumption appears to protect against non-alcoholic fatty liver disease.
Aliment Pharmacol Ther. 2011 Feb;33(3):378-88. doi: 10.1111/j.1365-2036.2010.04520.x. Epub 2010 Dec 1.
6
Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Arq Bras Endocrinol Metabol. 2010 Jun;54(4):362-8. doi: 10.1590/s0004-27302010000400004.
7
Epidemiology of non-alcoholic fatty liver disease.
Dig Dis. 2010;28(1):155-61. doi: 10.1159/000282080. Epub 2010 May 7.
8
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
N Engl J Med. 2010 May 6;362(18):1675-85. doi: 10.1056/NEJMoa0907929. Epub 2010 Apr 28.
9
Alcohol consumption and digestive cancer mortality in Koreans: the Kangwha Cohort Study.
J Epidemiol. 2010;20(3):204-11. doi: 10.2188/jea.je20090077. Epub 2010 Mar 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验